Creo Exim Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -21.99%
- Profit Growth 682.39%
- Ebitda 236.10%
- Net Worth 27.13%
- Total Assets -0.93%
About Creo Exim
Creo Exim Private Limited (CEPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2012 and has a history of 13 years. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Richa Sharma and Manoj Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900DL2012PTC230246
-
Company No.
230246
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jan 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Creo Exim Private Limited offer?
Creo Exim Private Limited offers a wide range of products and services, including Adhesives, Glue and Sealants, Tile and Floor Hardeners, Organic and Inorganic Solvents, Alcohol Solvents, Solvent Based Adhesives, Adhesive Gum, Dyes & Color Additives, Dye Intermediates, Rubber & Rubber Products, Natural Rubber.
Who are the key members and board of directors at Creo Exim?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Richa Sharma
|
Director | 19-Jan-2012 | Current |
|
Manoj Sharma
|
Director | 18-Mar-2016 | Current |
Financial Performance of Creo Exim.
Creo Exim Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 21.99% decrease. The company also saw a substantial improvement in profitability, with a 682.39% increase in profit. The company's net worth Soared by an impressive increase of 27.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Creo Exim?
In 2020, Creo Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Creo Exim?
Unlock and access historical data on people associated with Creo Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Creo Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Creo Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
